Systems and methods for real-time, transcranial monitoring of blood-brain barrier opening
US-2015065871-A1 · Mar 5, 2015 · US
US9302124B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9302124-B2 |
| Application number | US-201113045070-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 10, 2011 |
| Priority date | Sep 10, 2008 |
| Publication date | Apr 5, 2016 |
| Grant date | Apr 5, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Systems and methods for opening a tissue to a target value are disclosed herein. In an exemplary method, a region of the tissue is targeted for opening, a size range of microbubbles corresponding to the target value is determined, microbubbles of the size range are positioned in proximity to the targeted region, and an ultrasound beam is applied to the targeted region such that the tissue is opened with the assistance of the microbubbles to the target value.
Opening claim text (preview).
We claim: 1. A method for opening a tissue to a target value, comprising: targeting a region of said tissue for opening; selecting the target value based on a size of a molecule to pass through the tissue and a surface area of the region to be exposed to the molecule; determining a size range of microbubbles corresponding to said target value; generating a polydispersed microbubble distribution using acoustic emulsification; isolating the microbubbles of the size range from the polydispersed microbubble distribution using differential centrifugation; positioning the microbubbles of said size range in proximity to said targeted region; and applying an ultrasound beam to said targeted region such that said tissue is opened with the assistance of said microbubbles to said target value. 2. The method of claim 1 , further comprising determining a concentration range of microbubbles corresponding to said target value, and wherein positioning said microbubbles further comprises positioning said microbubbles of said concentration range. 3. The method of claim 1 , further comprising determining a pressure range for said ultrasound beam corresponding to said target value, and wherein applying said ultrasound beam comprises applying said ultrasound beam at said pressure range. 4. The method of claim 3 , wherein said pressure range corresponds to a resonance frequency of said microbubbles proximate to said targeted region. 5. The method of claim 1 , wherein said tissue comprises a blood-brain barrier. 6. The method of claim 1 , wherein said tissue comprises a vessel. 7. The method of claim 1 , further comprising applying an ultrasound beam to move said microbubbles into vessels of said tissue. 8. The method of claim 1 , wherein determining said size range of microbubbles comprises determining a size range corresponding to a size range of vessels of said tissue. 9. The method of claim 1 , wherein said size range of microbubbles is 4 to 5 microns. 10. The method of claim 1 , wherein said size range of microbubbles is 1 to 2 microns. 11. The method of claim 1 , wherein said size range of microbubbles is 9 to 10 microns. 12. The method of claim 1 , wherein said size range of microbubbles is 6 to 8 microns. 13. The method of claim 1 , wherein said microbubbles are acoustically activated microbubbles. 14. The method of claim 1 , wherein said microbubbles are molecule carrying microbubbles. 15. The method of claim 14 , wherein said molecule is a medicinal molecule. 16. The method of claim 14 , wherein said molecule is a contrast agent. 17. The method of claim 14 , wherein said molecule is a biomarker. 18. The method of claim 14 , wherein said molecule is a liposome. 19. The method of claim 14 , wherein said molecule carrying microbubbles are carrying a medicinal molecule and a contrast agent. 20. The method of claim 1 , further comprising positioning medicinal molecules in proximity to said targeted region. 21. The method of claim 1 , further comprising positioning a contrast agent in proximity to said targeted region. 22. The method of claim 1 , wherein the desired permeability comprises one or more of a size of a molecule to pass through the tissue, an area of the tissue to be opened, and a rate at which molecules pass through the tissue. 23. A method for imaging the opening of a tissue to a target value, comprising: targeting a region of said tissue for opening; selecting the target value based on a size of a molecule to pass through the tissue and a surface area of the region to be exposed to the molecule; determining a size range of microbubbles corresponding to said target value; generating a polydispersed microbubble distribution using acoustic emulsification; isolating the microbubbles of the size range from the polydispersed microbubble distribution using differential centrifugation; positioning the microbubbles of said size range in proximity to said targeted region; applying an ultrasound beam to said targeted region such that said tissue is opened with the assistance of said microbubbles to said target value; and collecting image information for said targeted region of said opening tissue. 24. The method of claim 23 , wherein imaging said targeted region comprises applying an ultrasound beam to said targeted region. 25. The method of claim 23 , wherein imaging said targeted region comprises utilizing a magnetic resonance imaging device to image said targeted region. 26. A system for opening a tissue to a target value, comprising: a targeting assembly for targeting a region of said tissue; a processor programmed with logic configured to: select the target value based on a size of a molecule to pass through the tissue and a surface area of the region to be exposed to the molecule; and determine a size range of microbubbles corresponding to said target value; a probe adapted to generate a polydispersed microbubble distribution using acoustic emulsification; a centrifuge adapted to isolate the microbubbles of the size range from the polydispersed microbubble distribution using differential centrifugation; and an introducer adapted to deliver a solution including the microbubbles of the size range to a location proximate to said targeted region; and a transducer, coupled to said targeting assembly, adapted to apply an ultrasound beam to said targeted region to thereby open said tissue with the assistance of said microbubbles to said target value. 27. The system of claim 26 , wherein the system comprises an imaging transducer. 28. The system of claim 26 , wherein said targeting assembly comprises one or more members for placement on an anatomical landmark of said tissue. 29. The system of claim 26 , wherein said solution of size-controlled microbubbles further comprises a microbubble concentration range corresponding to said target value. 30. The system of claim 26 , wherein said solution of size-controlled microbubbles further comprise microbubbles of a size range corresponding to a size range of vessels of said tissue. 31. The system of claim 26 , wherein said tissue comprises a blood-brain barrier. 32. The system of claim 26 , wherein said tissue comprises a vessel. 33. The system of claim 26 , wherein said size range of microbubbles is 4 to 5 microns. 34. The system of claim 26 , wherein said size range of microbubbles is 1 to 2 microns. 35. The system of claim 26 , wherein said size range of microbubbles is 9 to 10 microns. 36. The system of claim 26 , wherein said size range of microbubbles is 6 to 8 microns. 37. The system of claim 26 , wherein said microbubbles are acoustically activated microbubbles. 38. The system of claim 26 , wherein said microbubbles are molecule carrying microbubbles. 39. The system of claim 38 , wherein said molecule is a medicinal molecule. 40. The system of claim 38 , wherein said molecule is a contrast agent. 41. The system of claim 38 , wherein said molecule is a biomarker. 42. The system of claim 38 , wherein said molecule is a liposome. 43. The system of claim 38 , wherein said molecule carrying mi
for contrast media · CPC title
involving the use of contrast agents, e.g. microbubbles introduced into the bloodstream · CPC title
Ultrasound therapy (lithotripsy A61B17/22, A61B17/225; massage using supersonic vibration A61H23/00 {; using ultrasound for introducing media into the body A61M37/0092}) · CPC title
for diagnosis of the brain · CPC title
using microbubbles · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.